The department of pharmacology is located on the 2nd floor of administrative building. It is well equipped with, Computer Assisted Learning Lab (CAL Lab), Drug Museum, Seminar room equipped with audio-visual devices, Skill lab, Therapeutic Drug Monitoring Lab (TDM), PG Research lab with sophisticated instruments like Flow cytometer & High-Pressure Liquid Chromatography (HPLC).

The department is also equipped with photographs depicting various adverse drug reactions, charts pertaining to history of Pharmacology and various systems.

• To establish “Central Animal House” and make it functional for teaching and research purposes of PG students and Faculty members of the institute, which could benefit in research.
• To start “Drug and Poison Information Centre” that shall work as an operational unit which will provide up-to-date scientific and technical information on drugs and poisoning.
• To set up Clinical Pharmacology Unit (CPU) in the hospital building so that DM clinical Pharmacology may be started, it is also planning to establish a Drug Museum for better understanding of pharmacology.

• Skill lab of department of pharmacology provides training to the undergraduate and post graduate students on different routes of drug administration with the help of mannequins.
• Computer aided learning (CAL) lab is equipped to conduct simulated experiments for MBBS and MD training.
• Various research projects are undertaken by the department each year.
• Departmental pharmacy is involved in preparation of suitable dosage form when asked by concerned department.

• Collection and reporting of adverse drug reactions received from the hospital. Adverse drug monitoring centre (AMC), which is legitimately connected to National Coordination Centre, Ghaziabad, is in charge of monthly reporting of various ADRs acquired from hospital patients in the OPD and IPD.
• Adverse Events following immunization (AEFI) are also reported to NCC Ghaziabad every month.
• The department contributes in the research projects of other departments by helping in formulating desired dosage forms.
• A skill lab where hands on training is provided for various routes of drug administration to MBBS and MD students.

• The teaching and learning methodology of department include both conventional as well as modern methods. It includes didactic lecture and practical classes. Computer-based practical classes are being conducted.
• The department has completely phased out ‘animal experimentation’ at the UG level and is actively teaching experimental pharmacology using virtual simulation software – Ex Pharm Pro. (CAL lab.)
• Department also conducts a software based online exam of experimental pharmacology.
• Problem based learning has been initiated for both MBBS 2021 batch. Drug interactions, fixed dose combinations and causality assessment of adverse drug reactions are being taught to the students, both in lectures and in practicals. Prescription audit and analysis training has been started since 3rd semester (MBBS 2013 batch).
• Mannequin based simulation to reinforce Pharmacological concept has been started for MBBS and B.Sc. (Hons.) nursing students.

• Lectures and tutorial classes are held regularly. We are teaching the nurses about clinical aspect of pharmacology as well their responsibility towards patients.
• Mannequin based simulation to reinforce pharmacological concept has been started.

• Optimal training of the in-house staff is being carried out for teaching and research activities to start clinical services.
• Basic research related equipment and basic clinical services related equipment procurement is under process.

• Clinical Pharmacology Unit (CPU) is in process of standardizing available ‘equipment and processes’ with on-going validation procdeures, to start clinical trials.
• Regular training activities will be conducted for capacity building.

• The faculty members of the institute involve themselves in medical camps of community outreach health programme of the department of telemedicine, AIIMS Patna.

-

1. Sunil Kumar Singh, Shruti Singh, Rajesh Kumar, Ajay Sharma, Ritu Karwasra. An Updated Review on multidimensional uses of Bauhinia purpurea Linn. Eur. Chem. Bull. 2023, 12(Special Issue 5), 493 – 501
2. N Nimavat, MM Hasan, G Mandala, S Singh, R Bhangu, S Bibi. Mortality Rate in Schizophrenia. Cognizance of Schizophrenia:2023; A Profound Insight into the Psyche, 303-312
3. Insha E Rab, Pramod Kumar Manjhi, Divendu Bhushan, Shruti Singh, Sunil Kumar Singh, et al. (2023). 'Comparison of Efficacy and Safety of Metformin with Teneligliptin Versus Metformin with Glimepiride in Patients of Type 2 Diabetes Mellitus: An Open-Label Randomized Trial', European Journal of Molecular & Clinical Medicine, 10(3), pp. 312-322.
4. Mukesh Kumar, Pramod Kumar Manjhi, Shruti Singh, Soni, Dheeraj Kumar Singh, Sanmita Deo. Appraisal of Inter-Rater Agreement among Assessment Scales and Retrospective Analysis of Validated Reports of Cutaneous Adverse Drug Reactions at Tertiary Care Hospital in Eastern India. Journal of Clinical and Diagnostic Research. 2021 Feb, Vol-15(2): FC17-FC22
5. Manjhi PK, Kumar R Aakanksha P, Insha. Drug-Drug Interactions in Patients with COVID-19: A Retrospective Study at a Tertiary Care Hospital in Eastern India. MAEDICA – a Journal of Clinical Medicine 2021; 16(2): 269-275
6. Manjhi PK, Singh SK, Kumar R, Singh S, Priya A, Nishi. Drug Utilisation Study among COVID-19 Inpatients in a Tertiary Care Hospital in Eastern India. Int J Cur Res Rev 2021; |13 (11) : S210-214
7. Dr. Pramod Kumar M. Pharmacovigilance: A Step towards Patient Safety. Int J CurRes Rev. 13(20), October, 2021; 01 01,
8. Ravikirti, Roy, R., Pattadar, C., Raj, R., Agarwal, N., Biswas, B., Manjhi, P. K., Rai, D. K., Shyama, Kumar, A., & Sarfaraz, A. (2021). Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India. Journal of Pharmacy & Pharmaceutical Sciences, 24(3), 343–350. https://doi.org/10.18433/jpps32105
9. Manjhi PK, Singh SK, Kumar C, Rana AK. Rational use and cost variation analysis of antitussive-expectorants available in the Indian market: a pharmacoeconomic study. Int J Basic Clin Pharmacol 2021;10:1342-7.
10. Pramod Kumar M. The Five Ds for Rational Use of Antimicrobial Agents. Int J Cur Res Rev. 14(5), March, 2022, 01-02, http://dx.doi.org/10.31782/IJCRR.2022.14515
11. Dr. Rajesh Kumar, Dr, Pramod Kumar Manjhi, Dr. Sunil Kumar Singh, Dr. Shruti Singh, Dr. Chakrapani Kumar, Dr. Akhilesh Kumar Rana, “Awareness towards Antibiotic Resistance in Healthcare Undergraduate Students of Indian Tertiary Care Hospital,’’ IJMSAR – March – 2022; 5: 2, 56-69.
12. Dr. Pramod Kumar M. Pharmacogenomics: A Tool for Precision Medicine. Int J Cur Res Rev. 14(14), July, 2022, 01-02 https://doi.org/10.31782/IJCRR.2022.141404
13. Pramod Kumar M, Sadaram Samba S. Implementation of Antimicrobial Stewardship Program in Hospitals: An Urgent Need. Int J Cur Res Rev. 14(16), August, 2022, 01-02, https://doi.org/10.31782/IJCRR.2022.141603
14. Manjhi PK, Rana AK, Kumar R, Kumar C. A competency-based medical education on personal drug selection among medical students: a prospective, cross-sectional study. Int J Basic Clin Pharmacol 2022;11:597-601.
15. Manjhi PK, Kumar C, Rana AK. Rational use and cost variation analysis of antifungal drugs available in the Indian market: a pharmacoeconomic study. Int J Basic Clin Pharmacol 2022;11:602-6.Monday, May 8, 2023
16. Kumar V, Bhushan D, Supriya S, Ganapule AA, Lohani P, Shyama, et al. Efficacy of intravenous vitamin C in management of moderate and severe COVID‑19. J Family Med Prim Care 2022;11:4758-65.
17. Pramod Kumar Manjhi, Amit Patil: Forensic pharmacovigilance: An evolving subspecialty. Int J Cur Res Rev 14 (22) November, 2022,01-02 DOI URL: https://doi.org/10.31782/IJCRR.2022.142202
18. Rai DK, Manjhi PK. Mild COVID- 19 Infection: Do we have any effective drugs? A narrative review. Med J DY Patil Vidyapeeth 2022;15:S146-53.
19. Singh S, Singh CM, Ranjan A, Kumar S, Singh DK. Evidences suggesting a possible role of Vitamin D in COVID 19: The missing link. Indian J Pharmacol. 2021 Sep-Oct;53(5):394-402. doi: 10.4103/ijp.IJP_654_20. PMID: 34854410; PMCID:PMC8641745.
20. Nimavat N, Singh S*, Agrawal A, Rafi MA, Bhatti Parmar G, Ashish Shah. Mutations in SARS-CoV-2 genomes and future strategies. Clinical Epidemiology and Global Health. Volume 12,2021,100875,ISSN 2213-3984,
21. Kumar V, Ganapule A. Supriya S. Bhushan D, Lohani P, Pandey S, Sahoo B, Kumar A,Singh S, Kumar R. Efficacy of Montelukast in the management of COVID-19: double-blind randomized placebo-controlled trial. International Journal of Basic & Clinical Pharmacology, 2021;10(12), 1374-1379.
22. Agarwal M, Bhushan D, Singh S, Singh S. Determinants of Survival in obstetric Sepsis:Retrospective Observational Study. J Obstet Gynaecol India. 2022 Aug;72(Suppl1):159-165. doi: 10.1007/s13224-021-01611-w. Epub 2022 Feb 11. PMID: 35928076;PMCID: PMC9343490.
23. Nimavat N, Singh S*, Patel D, Singh P, Hasan MM, Mandala G, Bhangu R, Priya A.The Relationship Between Vitamin D Levels and Severity in Illness in COVID-19Patients: A Cross-Sectional Study. Cureus. 2022 Mar 14;14(3):e23146. doi:7759/cureus.23146. PMID: 35444872; PMCID: PMC9010000.
24. Nimavat N, Singh S*, Singh P, Singh SK, Sinha N. Vitamin D deficiency and COVID-19: A case Control study at a tertiary care hospital in India. Annals of medicine andsurgery 2021; 68:102661
25. Nimavat N, Singh S, Fichadiya N, Sharma P, Patel N, Kumar M et al. Online Medical Education in India- Different challenges and Probable solutions in the Age of COVID-Advances in Medical Education and Practice 2021:12 (237-243)
26. Singh S, Nimavat N, Kumar Singh A, Ahmad S, Sinha N. Prevalence of Low Level of Vitamin D Among COVID-19 Patients and Associated Risk Factors in India – A Hospital-Based Study. Int J Gen Med. 2021; 14:2523-2531
27. Singh S, Soni, Singh CM, Lohani P, Singh SK, Singh P.Knowledge, Attitude and Practice Related to the Use of Nutraceuticals for Prophylaxis against COVID-19 among Undergraduate Medical and Nursing Students in a Tertiary Care Teaching Hospital, Bihar, IndiaJ Clin of Diagn Res.2022; 16(7):FC01-FC06.
28. N Nimavat, D Patel, MM Hasan, G Mandala, S Singh, R Bhangu. Is it time to re-evaluate SDGs in the light of COVID-19 pandemic? Clinical Epidemiology and Global Health.2022; 15
29. Determinants of Survival in obstetric Sepsis: Retrospective Observational Study M Agarwal, D Bhushan, S Singh, S Singh. The Journal of Obstetrics and Gynecology of India 2022An Epidemiological Investigatio.;72 (Suppl 1), 159-165
30. Nirav Nimavat, Mohammad Mehedi Hasan, Sundip Charmode, Gowthamm Mandala, Ghanshyam R Parmar, Ranvir Bhangu, Israr Khan, Shruti Singh, Amit Agrawal, Ashish Shah, Vishi Sachdeva.COVID-19 pandemic effects on the distribution of healthcare services in India: A systematic review. World Journal of Virology.2022; 11 (4), 186
31. Kumar R, Singh S, Singh S K (October 29, 2022) A Systematic Review of 5110 Cases of Monkeypox: What Has Changed Between 1970 and 2022?. Cureus 14(10): e30841. DOI 10.7759/cureus.30841. PMID: 36451652
32. Singh S, Kumar R, Singh S K (November 04, 2022) All That We Need to Know About the Current and Past Outbreaks of Monkeypox: A Narrative Review. Cureus 14(11): e31109. DOI 10.7759/cureus.31109. PMID: 36475222
33. Manjhi PK, Rana AK, Kumar R, Kumar C. A competency-based medical education on personal drug selection among medical students: a prospective, cross-sectional study. Int J Basic Clin Pharmacol 2022; 11:597-601.
34. Kumar R, Misra AK, Dutta S, Gupta A, Kumar B, Charan J. A systematic review of mucormycosis cases in COVID 19: Is it an unholy trilogy of COVID 19, diabetes mellitus, and corticosteroids? J Family Med Prim Care 2022; 11:2573 80. PMID: 36119210
35. Kumar S, Saurabh MK, Narasimha VL, Maharshi V*. Efficacy of Interferon-β in Moderate-to-Severe Hospitalised Cases of COVID-19: A Systematic Review and Meta-analysis. Clin Drug Investig. 2021 Dec;41(12):1037-1046. doi: 10.1007/s40261-021-01092-9. Epub 2021 Oct 23. PMID: 34687413; PMCID: PMC8540871.
36. Maharshi V*, Kumar VL, Sarangi SC, Dutt Upadhyay A, Kumar A. Effect of ascorbic acid supplementation on pulmonary functions in healthy adults: a randomized controlled pilot study. J Basic Clin Physiol Pharmacol. 2021 Dec 16. doi: 10.1515/jbcpp-2021-0243. Epub ahead of print. PMID: 34914338.
37. Kumar S, Saikia D, Bankar M, Saurabh MK, Singh H, Varikasuvu SR, Maharshi V*. Efficacy of COVID-19 vaccines: a systematic review and network meta-analysis of phase 3 randomized controlled trials. Pharmacol Rep. 2022 Dec;74(6):1228-1237. doi: 10.1007/s43440-022-00429-1. PMID: 36342658; PMCID: PMC9640819
38. Maharshi V, Diksha D, Gupta P*. Quality Assessment of Pre-Clinical Studies of Chimeric Antigen Receptor T-Cell Therapy Products: A Point of Focus on Safety. CurrDrugSaf.2022;17(2):129-135. doi: 10.2174/1574886316666210728101333. PMID: 34323195
39. Maharshi V*, Puja P, Jakhar D, Singh V. Awareness among general public of India Towards COVID-19 Pandemic: A Questionnaire Based Cross Sectional Study. Br J Pharm Med Res. Feb, 2021;06:3046-59.
40. Kumar S, Saurabh MK, Maharshi V, Saikia D. A Narrative Review of Antiviral Drugs Used for COVID-19 Pharmacotherapy. J Pharm Bioallied Sci. 2021 Apr-Jun;13(2):163-171. doi: 10.4103/jpbs.JPBS_498_20. Epub 2021 May 26. PMID: 34349475; PMCID: PMC8291105.
41. Kumar S, Saurabh MK, Maharshi V*. Efficacy and safety of potential vaccine candidates against coronavirus disease 2019: A systematic review. J Adv Pharm Technol Res. 2021 Jul-Sep;12(3):215-221. doi: 10.4103/japtr.JAPTR_229_20. Epub 2021 Jul 16. PMID: 34345597; PMCID: PMC8300322.
42. Shruti Singh, Nirav Nimavat, Chandramani Singh, Alok Ranjan, Mala Mahto, Sunil Kumar Singh, Amarjeet Kumar, Swetalina Pradhan. Journal of family medicine and primary care. 2022; Journal of family medicine and primary care
43. Manjhi PK, Sinha RI, Kumar M, Sinha KI. Comparative study of efficacy of oral ivermectin versus some topical antiscabies drugs in the treatment of scabies. JCDR 2014; 8(9): HC01-HC04.
44. Kumar M, Pathak AK, Manjhi PK, Mohan L, Dikshit H. Study of changes in serum lipid profile and blood sugar level by perindopril and telemisartan during treatment of systemic hypertension. IJBCP 2014; 3(3): 454-459.
45. Manjhi PK, Mohan L, Kumar M, Dikshit H, Singh BP. Prescription pattern of fixed dose drug combination in cardiology department in a tertiary care hospital. IJBCP 2016; 5(3): 951-955.
46. Manjhi PK, Mishra H, Dikshit H, Mohan L, Kumar M. Prescription pattern of antimicrobial drugs in paediatric outpatient department in a tertiary care teaching hospital. International Journal of Pharmaceutical Sciences Review and Research Volume 40 (2) September-October 2016; 245-250.
47. Manjhi PK, Kumar M, Dikshit H, Mohan L, Mishra H. A survey on knowledge, attitude and practice of pharmacovigilance and adverse drug reaction (adr) reporting among healthcare professionals in a tertiary care hospital of Bihar. Int J Basic Clin Pharmacol. 2016 Dec;5(6):2566-2571.
48. Manjhi PK, Kumar M, Dokania S, Dikshit H, Mohan L, Mishra H. Cutaneous adverse drug reactions notified by adr monitoring centre in a tertiary care hospital of Bihar. Journal of Pharmacovigilance & Drug Safety Volume 12 (4) October-December, 2015:71-72.
49. Mishra H, Dikshit H, Mohan L, Kumar M, Manjhi PK. Information in package insert: A study in Eastern India. International Journal of Pharmacological Research Volume 6 Issue 12 (2016), 349-352.
50. Manjhi PK, Dikshit H, Mohan L, Mishra H, Kumar M, Dokania S. Adverse reactions due to cosmetics notified by ADR monitoring centre in a Tertiary Care Hospital. Journal of Drug Safety 2016, Vol.39, No.10(pp.999)
51. Kumar M, Kumar M, Mishra H, Manjhi PK, Chandra A, Mohan L, et al. Undergraduate medical students’ perception regarding computer assisted learning in experimental pharmacology practical. Int J Basic Clin Pharmacol 2018;7: 541-7.
52. Sinha RI, Kumar M, Prasad NK, Manjhi PK, Sinha KI. Ondansetron alone and ondansetron with dexamethasone in the prevention of post- operative nausea and vomiting in patients undergoing abdominal surgery: A prospective, randomized open label comparative study. International Journal of Contemporary Medicine July- Dec. 2018; Vol. 6 No. 2 (7-12).
53. Soni, Manjhi PK, Kumar M and Singh DK. Problem-Based Question Oriented Learning in Understanding the P-drug Concept among Medical Undergraduates. J Clin & Exp Pharmacol 2019 Vol. 9 Issue 1: 258.
54. Gupta PP, Singh S, Mishra R, Manjhi PK, Kunal. Reporting pattern of adverse drug reaction in a newly set up hospital at AIIMS Patna – A preliminary study. British Journal of Pharmaceutical and Medical Research. May- June 2019; 03 (03) :1913-1921.
55. Singh DK, Soni, Manjhi PK, Singh S, Kumar M. Perception Of Medical Students On Online Versus Traditional Teaching At A Tertiary Care Teaching Hospital Of Eastern India. British Journal of Pharmaceutical and Medical Research. July- Aug. 2020; 05 (04): 2508-2514.
56. Tarun Kumar, Siddhartha Dutta, Rajit Sahai, Sameer Khasbage, Rajesh Kumar, Sudeshna Banerjee. Dermatological Manifestations of COVID-19. A Review Based on Existing Reports. International Journal of Current Research and Review.2020;12(13):65-68
57. Kumar R, Misra AK, Dutta S, Sharma PK. Role of Cannabis in Diabetic Neuropathy: Is This the Therapeutic Agent? Int. J. Pharm. Sci. Rev. Res.2019; 55(2):60 - 63
58. Ambwani S, Misra AK, Kumar R. "Medication Errors: Is it the hidden part of the submerged iceberg in our healthcare system?". International Journal of Applied and Basic Medical Research. 2019; 9(3): 135-142. PMID: 31392175
59. Kumar R, Sharma PK, Misra AK, Gupta A. Role of Bisphosphonate (Bps) in Breast Cancer: An Update. Clinics of Oncology.2018; 1(2): 1-5
60. Dutta S, Sharma PK, Misra AK, Kumar R, Rai S, and Chaudhary R.A Case Report on Warfarin Induced Skin Necrosis:Drug-drug Interaction or Inappropriate Therapy.J Pharm Sci Therap 2018;4(1):230-233.
61. Sharma PK, Misra AK, Gupta A, Kumar R, Singh S. Drug Induced Reaction: Dilemma of Finding a Real Culprit. Ann Pharmacol Pharm. 2018; 3(4): 1155.
62. Maharshi V*, Rehan HS, Gupta LK, Yadav M. Comparison of effect of enalapril and losartan monotherapy on quality of life and safety of stage 1 hypertensive patients. Indian Journal of Physiology and Pharmacology. 2016 Apr;60 (2):174-181. PMID 29809375.
63. Rehan HS, Andley M, Nagar P, Maharshi V*. Unstable angina: A serious adverse event following gemcitabine-cisplatin based chemotherapy. Journal of the Association of Physicians of India. 2016 Sep;64(9):85-86. PMID 27762526.
64. Arora T, Maharshi V*, Rehan HS, Nagar P. Blepharospasm: an uncommon adverse effect caused by long-term administration of olanzapine. Journal of Basic and Clinical Physiology and Pharmacology. 2017 Jan 1;28(1):85-87. PMID 27658142.
65. Maharshi V*, Nagar P. Chronic administration of phenytoin and pleomorphic adenoma: A case report and review of literature. Indian Journal of Pharmacology. 2017 Jan-Feb;49(1):130-131. PMID 28458439, PMCID, PMC5351228.
66. Maharshi V*, Hasan S. Nusinersen: The first option beyond supportive care for spinal muscular atrophy. Clinical Drug Investigation. 2017 Sep;37(9):807-817. PMID 28755059.
67. Maharshi V*, Nagar P. Comparison of online reporting systems and their compatibility check with respective adverse drug reaction reporting forms. Indian Journal of Pharmacology. 2017 Sep-Oct;49(5):374-382. PMID 29515278, PMCID PMC5830848.
68. Maharshi V*, Banerjee I, Nagar P, Rehan HS. Tracheo-esophageal fistula (TEF) in a newborn following maternal antenatal exposure to olanzapine. Drug Safety Case Reports. 2017 Dec;4(1):1-4. PMID 28063029, PMCID PMC5218954.
69. Maharshi V, Gupta P, Kumar VL, Upadhyay AD, Das P, Yadav R, Nayak B, Kumar R, Shalimar. Effect of Helicobacter pylori-eradication therapy on hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomized-controlled pilot study. Gastroenterol Rep (Oxf). 2019 Nov 25;8(2):104-110. doi: 10.1093/gastro/goz058. PMID: 32499918; PMCID: PMC7261206.
70. Saurabh MK, Kumar S, Maharshi V. Evaluation of Medicine Exposure During Pregnancy at a Tertiary Center of an Indian State. Maedica (Bucur). 2020; 15:503-12. PMID: 33603908; PMCID: PMC7879351; DOI: 10.26574/maedica.2020.15.4.503.
71. Kumar S, Kumar R, Gupta YK, Singh S. In vivo anti-arthritic activity of Bauhinia purpurea Linn. Bark Extract. Indian J Pharmacol. 2019 Jan-Feb;51(1):25-30. doi: 10.4103/ijp.IJP_107_16. PMID: 31031464; PMCID: PMC6444833.
72. R Mishra, SK Jeevangi, S Vardhamane, S Kumar. Pharmacovigilance study in medicine department in a tertiary care hospital. Int J Basic Clin Pharmacol.2016; 5, 2608-15
73. Dr. Sunil Kumar Singh and Syed Meraj Fatmi Dr. Rajat Mishra*, Kunal Prasad. A case report of ornidazole and ofloxacin drug combination induced generalised body swelling and itching with fever. European Journal of Biomedical AND Pharmaceutical sciences.2018;5(7,);647-648
74. Rajat Mishra, Syed Meraj Fatmi, Sunil Kumar Singh. Knowledge and awareness about pharmacovigilance among 2 nd year mbbs students at government medical college and hospital. World Journal of Pharmaceutical Research.2018;7(7);913-924.
75. R Mishra, SM Fatmi, SK Singh. Practice of self-medication among medical students of government medical college and teaching hospital. World journal of pharmaceutical and medical research. 2017; 3 (5), 187-191
76. Prashant Kumar Singh, Khempal Singh, Kamlesh Bharati, Shruti Singh. A RARE CASE REPORT; PRIMARY INTRAHEPATIC PREGNANCY. Journal of Surgical Arts.2012;5(2), 45-47
77. RDK Singh S, Singh PK. Burden of Adverse Drug Reactions encountered during management of Chronic Respiratory diseases in a newly set up tertiary care hospital: A cross sectional study. International Journal of Scientific Research.2017; 6 (8), 129-132
78. S Singh, PK Singh. Near Fatal Anaphylactoid Reaction Due to Bupivacaine Spinal Anaesthesia. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH.2018; 12 (3), UD01-UD02
79. KK Gupta PP, Singh S, Mishra R, Manjhi PK. Reporting pattern of Adverse drug reactions in a newly set up Tertiary Care Hospital–A preliminary study. 2019; British Journal of Pharmaceutical and Medical Research 4 (3), 1913-1921
80. S Singh, PK Singh. Pattern and impact of drugs targeted toward toxicity amelioration in patients receiving cancer chemotherapy.2018; Perspectives in clinical research 9 (1), 23
81. M Bisht, S Singh, DC Dhasmana. Effect of educational intervention on adverse drug reporting by physicians: a cross-sectional study.2014; International Scholarly Research Notices 2014

1. CME cum E-Workshop on Materiovigilance (25/03/2021)
   Topic: Ensuring Safety of Medical devices “A vital step towards Patient safety”


2. National Pharmacovigilance Week from 17th to 23rd September ,2021
   Topic: “Encouraging reporting of Adverse Drug reactions by Patients”
   Speaker: Dr. Rajeev Singh Raghuvanshi, Secretary-cum-Scientific, Director, IPC
   Dr. Jai Prakash, Sr. Prinicpal Scientific Officer, IPC
   Dr. Santanu K. Tripathi, Dean & Prof. NSMCH Patna
   Dr. Bikash Medhi, Prof. & AMC Coordinatior, Dept. of Pharmacolgoy, PGIMER Chandigarh


3. CME program on Materiovigilance on 25/03/2022
   Topic: Ensuring the Safety of Medical Devices
   Speaker: Dr. V. Kalaiselvan, Principal Scientific Officer, IPC
   Dr. Shatrunjay Shukla, IPC
   Ms. Amrutha, Sree Chitra Tirunal Institute of Medical Sciences & Technology


4. Guest lecture at 20/02/2022
   Topic: Research in resource-constrained settings.
   Speaker: Dr. Debashish Hota , Dean & Prof. , AIIMS Bhubaneswar


5. National workshop on “Clinical trial Fundamentals Hands-on” 11-13th May 2023

• pharmacology@aiimspatna.org